ASRT vs SBUX · rev $125.0M vs P/E 76, rev $37.18B
Assertio Therapeutics Inc (ASRT) versus Starbucks Corporation (SBUX) — a side-by-side from cached financials, not a winner call.
Assertio Therapeutics Inc (ASRT) is a drug manufacturers - specialty & generic company listed on US.
Starbucks Corporation (SBUX) is a restaurants company listed on NASDAQ. It is led by Brian Niccol.
Latest reported ASRT revenue for 2024-12-31 was $125.0M. Net income was -$21.6M. Revenue was down 17.8% from 2023-12-31 to 2024-12-31. ASRT currently screens at market cap $151.5M.
Latest reported SBUX revenue for 2025-09-28 was $37.18B. Net income was $1.86B. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
ASRT currently screens at market cap $151.5M. SBUX currently screens at market cap $113.76B and trailing P/E 76.2.
Not investment advice. Open the ASRT and SBUX stock pages for the full models.
Not investment advice.